Roman J. Fleck

NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.

Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH.

Kong, Inc. provides a marketplace to manage, distribute and consume both private and public application programming interfaces. It allows developers to search its directory to find appropriate applications for specific projects. The firm's applications are used by cloud proxies. The company was founded by Marco Palladino, Augusto Marietti and Michele Zonca in July 2009 and is headquartered in San Francisco, CA.

Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France.

Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.

Eight Roads Capital Advisors (UK) Ltd (Eight Roads Capital Advisors) is a venture capital subsidiary of FIL Ltd. founded in 1969. The firm is headquartered in London.

Conor Venture Partners Oy (Conor) is a venture capital firm founded in 2005 by Manu Mäkelä and Sami Ahvenniemi. The firm is headquartered in Espoo, Finland.

OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland.

Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.

Behaviometrics AB provides real-time monitoring and security services. The firm operates as a behavioral biometrics security company targeting the fintech industry. Its products identify the user while working on a computer, logging in to a web service, or tapping away on a phone. The firm develops frictionless behavioral user verification and authentication services such as BehavioAion, which monitors keystroke and mouse behavior in real-time for continuous authentication; BehavioWeb, which use keystroke dynamics for backend consumer verification in online or mobile services; and BehavioMobile, which use gesture, PIN-pad, or typing behavior for smart phone applications. The company was founded by Nils Olov Ingvar Renberg, Kristofer Nygren, Neil Costigan, Peder Nordström, Leif Peder Nordström, and Jonas Johansson in 2006 and is headquartered in Stockholm, Sweden.

LinguaFlex, Inc. develops, manufactures and distributes medical devices for the treatment of sleep apnea. It offers the LinguaFlex Tongue Retractor which is a minimally invasive device designed to be inserted into the tongue by a thin needle. The LinguaFlex Tongue Retractor is designed not to interfere with normal tongue functions such as speech and swallowing and to be removed or replaced in a doctor’s office in a short period of time without the need for anesthesia. The company was founded by Ira Sanders in 2007 and is headquartered in Pittsburgh, PA.

ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.

Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland.

Jasper Ridge Partners LP /Private Equity/ is the private equity arm of Jasper Ridge Partners LP headquartered in the US, California. It was founded in 2013 by Mark Alan Wolfson.

Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA

Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom.

DMC Partners (London) Ltd. engages in investment activities. The firm intends to invest in China, Russia, Southeast Asia, Turkey and sub-Saharan Africa regions. The company founded by Edward Kirill Eisler, Samuel Jonathan Wisnia and Christopher Michael Barter and is headquartered in London, the United Kingdom.

Verto Analytics, Inc. provides digital media measurement services. It provides a portfolio of solutions covering the digital and hardware ecosystems across various platforms, enabling clients to access insights through a single-source media measurement methodology. The firm offers Verto content watch and Verto device watch. It also offers custom research solutions that are tailored to different business needs. The company was founded in 2013 and is headquartered in New York, NY.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.

Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands.

Verto Analytics Oy provides cloud-based media measurement services. It specializes in mobile analytics, app analytics, mobile market research, audience measurement, market research, mobile network analytics and digital business analytics solutions. The company was founded by Hannu Tapani Verkasalo in 2012 and is headquartered in Espoo, Finland.

Kymo Therapeutics Ltd. develops and commercializes therapeutic products . The company was founded on May 23, 2016 and is headquartered in Hatfield, the United Kingdom.

Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA.

Mavalon Therapeutics Ltd. develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients. The company is headquartered in Hatfield, the United Kingdom.

Kaerus Bioscience France SASU engages in research and development in biotechnology. The company was founded on February 23, 2017 and is headquartered in Orléans, France.

Gremlin, Inc. develops and provides a suite of tools for chaos engineering. It offers Gremlin which provides the framework to simulate real outages with an ever-growing library of attacks. The company was founded by Kolton Andrus and Matthew Fornaciari and is headquartered in San Jose, CA.

Tekion Corp. engages in the development of business applications. Its product is as dSE, an end-to-end digital technology for both consumers and dealership personnel that connects the entire service experience from appointment scheduling to payment and everything in-between. The company was founded by Jayaprakash Vijayan and Guru Sankararaman in 2016 and is headquartered in San Ramon, CA.

Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom.

Villaris Therapeutics, Inc. is an asset-centric biopharmaceutical company. The company is based in Cary, NC. The company was founded in 2019 by John Harris. The CEO is Andrea Epperly.